The Waiting Game: Patenting Embryonic Stem Cells in Canada

24 Pages Posted: 26 Apr 2007

Date Written: April 11, 2007

Abstract

The main focus of this paper is the patentability of human embryonic stem cells ("hESC") in Canada. Its vast therapeutic and economic potential notwithstanding, Canada is yet to grant a patent on products of hESCs research. This paper, therefore, discusses the embryonic stem cell patent regime globally, in Europe and the U.S with a view to making recommendations on the best approach for dealing with embryonic stem cell patents in Canada.

Keywords: Embryonic stem cells, patents, patents laws and policies

JEL Classification: O3, 031, 034.

Suggested Citation

Ohioze, Idowu Andrew, The Waiting Game: Patenting Embryonic Stem Cells in Canada (April 11, 2007). Available at SSRN: https://ssrn.com/abstract=981830 or http://dx.doi.org/10.2139/ssrn.981830

Idowu Andrew Ohioze (Contact Author)

affiliation not provided to SSRN ( email )

No Address Available

Register to save articles to
your library

Register

Paper statistics

Downloads
183
rank
161,076
Abstract Views
1,168
PlumX Metrics